Managing Intangible Property Of Japanese Multinational Companies In M&A Context

Figure 1 Stock and Asset Purchase

by KPMG
In recent years, Japanese multinational companies have been acquiring an increasing number of foreign companies or divisions of companies. Although the acquisition of existing foreign companies or business divisions has been an effective means for Japanese multinational companies to quickly expand their business into foreign and new markets, it has created difficulties related to integrating the management of the acquired foreign companies or business divisions. […] Read more

2016 Asian Trailblazers Study: Masters Of Multitasking And Transformation

Figure 1. Asian Trailblazers are fine-tuning their strategy along several areas

by Willis Towers Watson
In 2012, an event occurred that went largely unnoticed. For the first time, the percentage of Asia Pacific-headquartered companies in the Fortune Global 500 outnumbered those headquartered in Europe and North America. That year, 36% of companies in the Fortune Global 500 were headquartered in Asia Pacific. Of these 181 organisations, 69 were headquartered in Mainland China and 68 in Japan. […] Read more

Global Capital Confidence Barometer – Buying And Bonding: Alliances Join M&A As Engines Of Growth

Figure 1 Key MA findings

by Ernst & Young
Our latest Global Capital Confidence Barometer continues to find a strong acquisition appetite together with a growing inclination to forge new alliances. Prolonged economic challenges are driving investment decisions, leading companies to ally and cooperate to generate growth as well as compete and acquire to gain market share. […] Read more

Taxation Of Cross-Border Mergers And Acquisitions: Japan 2016

Taxation Of Cross-Border Mergers And Acquisitions: Japan 2016

by KPMG
For the last few years, Japan has been reducing corporate income tax rates, and, by virtue of tax reform 2016, the effective tax rate is expected to drop below 30 percent. But to make up for tax revenues lost due to the reduced tax rates, various countermeasures have been introduced such as a limitation on the amount of deductible tax losses brought forward in a year. […] Read more

2016 Global Chemical Industry Mergers And Acquisitions Outlook: A Quest For Focus

2016 Global Chemical Industry Mergers And Acquisitions Outlook: A Quest For Focus

by Deloitte
In the Deloitte Touche Tohmatsu Limited (Deloitte Global) 2015 Global chemical industry mergers and acquisitions outlook, record levels of chemical mergers and acquisitions (M&A) activity in 2014 were observed, with a prediction that strong M&A momentum would continue in the industry into 2015. While the number of global chemical deals was relatively flat in 2015, the strong M&A momentum has continued with the number of global chemical deals in 2015 exceeding the previous six-year average by over 6 percent. […] Read more

The Deloitte M&A Index – 2016: Opportunities Amidst Divergence

M&A Index – 2016: Opportunities Amidst Divergence

by Deloitte
We are expecting 2015 to end with over $4 trillion worth of deals making it the highest for deal values since 2007. However, on a last-twelve-months (LTM) basis, there was a slowdown in the volume of transactions in the second half of 2015. Cross-border deals are a major feature of this M&A wave. More than $1 trillion worth of cross-border deals have been announced so far this year, of which a third were in the vibrant deal corridor between North America and Europe. […] Read more

Asia-Pacific Health Industries 2015: Keeping You Up-To-Date With The Latest Developments

Asia-Pacific Health Industries Newsletter 2015

by PricewaterhouseCoopers
There is no other sector as important as health. Health matters to each of us as individuals. It is our most precious and valuable asset and connects us all like no other. Health also matters to society. It lies at the heart of our economic, political, social and environmental prosperity and is now the world’s largest industry – with a value and cost three times greater than the banking sector. […] Read more

Die größten Pharmaunternehmen der Welt

Figure 1 Analysierte Unternehmen

by Ernst & Young
Eine Analyse wichtiger Finanzkennzahlen für die Geschäftsjahre 2012, 2013 und 2014. Analysiert wurden die Pharma-Umsätze der 20 weltweit umsatzstärksten börsennotierten Pharma-Unternehmen. Branchenfremde Aktivitäten sind nicht in die Analyse eingeflossen. Quellen: Geschäftsberichte, Pressemitteilungen der Unternehmen, SEC-Filings. […] Read more

Chemicals M&A: Emerging Technologies

Chemicals M&A: Emerging Technologies

by Accenture
Mergers and acquisitions in the global chemicals industry have tumbled from their highs of the 2007­-2009 period, jolted by the Great Recession and despite the steady, albeit gradual, recovery in chemicals markets since then, M&A has not returned to those past levels. The reasons for the M&A slowdown are likely due to the uncertainty of global economic health, greater diligence in managing financials (i.e. debt and cash), volatile exchange rates and prices and a digestion of the major acquisitions of the recent past. […] Read more

Are you sure you
want to log out?

Request a Brochure

Request a Brochure

Contact us to discuss your goals and needs!

Contact us to discuss your goals and needs!

Book a Demo

Book a Demo

Contact us to discuss your goals and needs!

Contact us to discuss your goals and needs!